Insight
Federation of State Medical Boards Weighs In on Ethical Use of AI in Clinical Practice
by Amy M. Joseph and Jeremy D. Sherer
5 minute read | September.04.2024
by Amy M. Joseph and Jeremy D. Sherer
5 minute read | September.04.2024
by Amy Walsh
6 minute read | September.04.2024
What should public life sciences companies should know about expansive new theories of liability in two insider trading cases?
by Amy M. Joseph and Jeremy D. Sherer
7 minute read | August.15.2024
Federal agencies and lawmakers in several states are attempting to rewrite the rulebook for private investment in health care in the U.S.
by Thora Johnson, Alyssa Wolfington and Michaela Frai
5 minute read | July.29.2024
by Eileen M Cole, Craig Falls, Thora Johnson and David Rhinesmith
9 minute read | July.08.2024
21 minute read | June.26.2024
by Irena Royzman Ph.D. and Lauren Drake
5 minute read | May.22.2024
The Supreme Court should reverse a decision on statutory patent term guarantees for Patent Office delays, Orrick’s Irena Royzman and Lauren Drake say.
by Thora Johnson and Peter Graham
2 minute read | May.01.2024
Legislators in Colorado have passed the first law in the United States meant to protect a consumer’s brainwaves.
by Thora Johnson and Cosmas Robless
7 minute read | April.30.2024
25 minute read | February.26.2024
Women's & Reproductive Health
by Thora Johnson, Cosmas Robless and Michaela Frai
5 minute read | February.15.2024
by Stephen Thau, Albert Vanderlaan and George Pothoulakis
6 minute read | January.30.2024
Reverse mergers have helped biotech companies access public markets, but recent SEC positions are threatening that path to going public.